We are live on ! Find out more

25 hedge funds and large institutions have $701K invested in cbdMD in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

0% more funds holding

Funds holding: 2525 (0)

0% more ownership

Funds ownership: 8.96%8.96% (+0%)

35% less capital invested

Capital invested by funds: $1.08M → $701K (-$383K)

Holders
25
Holders Change
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
5
Reduced
3
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
26
Citigroup
New York
-$42.4K -31,400 Closed
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
-$16.2K -11,966 Closed
SG
28
StoneX Group
New York
-$15.4K -11,375 Closed
CP
29
Camelot Portfolios
Ohio
-$4.39K -3,250 Closed
TRCT
30
Tower Research Capital (TRC)
New York
-$2.57K -1,901 Closed
Bank of America
31
Bank of America
North Carolina
-$108 -80 Closed

YCBD Hedge Fund Activity: Q1 2026 in Review

25 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q1 2026, worth a combined $701K — down 35% from $1.08M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new YCBD positions and 7 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, adding an estimated $132K. The largest seller was Worth Venture Partners, cutting an estimated $71.3K.

  • 25 institutional investors held cbdMD (YCBD) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $701K of cbdMD stock for Q1 2026, down 35% quarter-over-quarter.
  • 8 funds opened new cbdMD positions in Q1 2026 and 7 closed out, a net change of +1 holder.
  • The largest cbdMD buyer in Q1 2026 was UBS Group, an estimated $132K added.
  • The largest cbdMD seller in Q1 2026 was Worth Venture Partners, an estimated $71.3K sold.

Based on aggregated 13F filings for Q1 2026.